Royal Bank of Canada
LLY icon

Royal Bank of Canada’s Eli Lilly LLY Stock Holding History

Royal Bank of Canada’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.92B Sell
4,262,531
-107,202
-2% -$109M 0.69% 26
2025
Q4 		$4.7B Buy
4,369,733
+314,409
+8% +$301M 0.76% 25
2025
Q3 		$3.09B Buy
4,055,324
+222,125
+6% +$165M 0.51% 32
2025
Q2 		$2.99B Buy
3,833,199
+29,553
+0.8% +$23M 0.54% 32
2025
Q1 		$3.14B Buy
3,803,646
+1,082,268
+40% +$901M 0.66% 30
2024
Q4 		$2.1B Buy
2,721,378
+166,973
+7% +$138M 0.42% 44
2024
Q3 		$2.26B Buy
2,554,405
+144,245
+6% +$130M 0.46% 39
2024
Q2 		$2.18B Buy
2,410,160
+77,593
+3% +$62.1M 0.5% 37
2024
Q1 		$1.81B Sell
2,332,567
-18,901
-0.8% -$13.5M 0.42% 48
2023
Q4 		$1.37B Buy
2,351,468
+132,425
+6% +$77.3M 0.32% 65
2023
Q3 		$1.19B Sell
2,219,043
-144,310
-6% -$74.4M 0.32% 71
2023
Q2 		$1.11B Buy
2,363,353
+74,649
+3% +$31.3M 0.29% 73
2023
Q1 		$786M Sell
2,288,704
-190,252
-8% -$64.2M 0.22% 94
2022
Q4 		$907M Buy
2,478,956
+121,452
+5% +$43.1M 0.26% 83
2022
Q3 		$762M Buy
2,357,504
+47,923
+2% +$15.2M 0.24% 84
2022
Q2 		$749M Buy
2,309,581
+24,818
+1% +$7.45M 0.22% 95
2022
Q1 		$654M Sell
2,284,763
-146,497
-6% -$37.7M 0.16% 120
2021
Q4 		$672M Buy
2,431,260
+17,106
+0.7% +$4.34M 0.15% 126
2021
Q3 		$558M Sell
2,414,154
-40,358
-2% -$9.96M 0.15% 130
2021
Q2 		$563M Sell
2,454,512
-62,295
-2% -$12.5M 0.15% 126
2021
Q1 		$470M Sell
2,516,807
-240,474
-9% -$47M 0.14% 134
2020
Q4 		$466M Sell
2,757,281
-28,229
-1% -$4.21M 0.13% 148
2020
Q3 		$412M Buy
2,785,510
+347,214
+14% +$53.7M 0.15% 146
2020
Q2 		$400M Buy
2,438,296
+416,114
+21% +$63.9M 0.16% 133
2020
Q1 		$281M Buy
2,022,182
+43,456
+2% +$5.97M 0.14% 148
2019
Q4 		$260M Sell
1,978,726
-90,199
-4% -$10.5M 0.09% 196
2019
Q3 		$231M Buy
2,068,925
+64,618
+3% +$7.19M 0.09% 200
2019
Q2 		$222M Buy
2,004,307
+33,922
+2% +$3.99M 0.09% 196
2019
Q1 		$256M Sell
1,970,385
-396,512
-17% -$48.2M 0.11% 172
2018
Q4 		$274M Sell
2,366,897
-203,688
-8% -$22.8M 0.13% 147
2018
Q3 		$276M Buy
2,570,585
+124,357
+5% +$12.4M 0.11% 151
2018
Q2 		$209M Sell
2,446,228
-165,683
-6% -$13.6M 0.09% 186
2018
Q1 		$202M Sell
2,611,911
-2,128,621
-45% -$171M 0.09% 189
2017
Q4 		$400M Buy
4,740,532
+272,726
+6% +$23.2M 0.18% 103
2017
Q3 		$382M Sell
4,467,806
-285,302
-6% -$23.4M 0.18% 101
2017
Q2 		$391M Buy
4,753,108
+477,663
+11% +$39M 0.2% 94
2017
Q1 		$360M Buy
4,275,445
+1,735,191
+68% +$139M 0.19% 94
2016
Q4 		$187M Sell
2,540,254
-19,728
-0.8% -$1.47M 0.1% 161
2016
Q3 		$205M Sell
2,559,982
-1,282,609
-33% -$103M 0.12% 157
2016
Q2 		$303M Buy
3,842,591
+1,110,376
+41% +$83.6M 0.18% 95
2016
Q1 		$197M Sell
2,732,215
-1,331,930
-33% -$101M 0.12% 132
2015
Q4 		$342M Buy
4,064,145
+1,160,035
+40% +$96.3M 0.23% 83
2015
Q3 		$243M Sell
2,904,110
-419,181
-13% -$35.4M 0.18% 88
2015
Q2 		$277M Sell
3,323,291
-159,592
-5% -$12.2M 0.19% 81
2015
Q1 		$253M Sell
3,482,883
-770,961
-18% -$54.9M 0.18% 88
2014
Q4 		$293M Buy
4,253,844
+528,235
+14% +$35.7M 0.19% 84
2014
Q3 		$242M Buy
3,725,609
+17,559
+0.5% +$1.11M 0.17% 92
2014
Q2 		$231M Sell
3,708,050
-33,755
-0.9% -$2.01M 0.16% 99
2014
Q1 		$220M Buy
3,741,805
+1,045,874
+39% +$58.4M 0.16% 88
2013
Q4 		$137M Sell
2,695,931
-391,601
-13% -$19.6M 0.1% 158
2013
Q3 		$155M Buy
3,087,532
+691,550
+29% +$36.2M 0.12% 122
2013
Q2 		$118M Buy
+2,395,982
New +$130M 0.1% 134

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Royal Bank of Canada's LLY Position: Q1 2026 in Review

Royal Bank of Canada reduced its Eli Lilly (LLY) stake by 2.5% in Q1 2026, selling an estimated $109M and leaving 4,262,531 shares worth $3.92B. The position accounts for 0.69% of the portfolio, ranked #26.

Royal Bank of Canada first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.7B in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Royal Bank of Canada held 4,262,531 shares of Eli Lilly worth $3.92B as of Q1 2026.
  • Royal Bank of Canada sold 107,202 Eli Lilly shares in Q1 2026, an estimated $109M.
  • Eli Lilly made up 0.69% of Royal Bank of Canada's portfolio in Q1 2026, its #26 holding.
  • Royal Bank of Canada first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Eli Lilly position peaked at $4.7B in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.